The fight against cancer is global. Our focus must be as well.

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Dear Colleagues,

Today, our world is small. It feels smaller all the time. In a few hours we can get to any point on the globe. 

We routinely attend meetings where one or more people are in Europe, the Middle East, or Africa, joining remotely. In the cancer community, it is rare not to have friends and collaborators who are all over the world, and that is one of the truly special parts of this career.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
W. Kimryn Rathmell, MD, PhD, MMHC
Former director, National Cancer Institute
Table of Contents

YOU MAY BE INTERESTED IN

A study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer to develop resistance to therapy. Researchers at Baylor College of Medicine showed that lipid accumulation in tumor cells and nearby immune cells promotes immune suppression, but disrupting lipid formulation reverses treatment resistance and the immunosuppressive microenvironment.
W. Kimryn Rathmell, MD, PhD, MMHC
Former director, National Cancer Institute

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login